Ezetrol will be the first "cholesterol absorption inhibitor" for hyperlipidemia

December 2002

Ezetrol will be the first "cholesterol absorption inhibitor" for hyperlipidemia.

It just got approved in the U.S. under the name Zetia. It's now being considered in Canada.

It's different than other drugs that block cholesterol absorption.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

new approaches for preventing a SECOND heart attack
rheumatoid arthritis patients getting BOTH methotrexate plus Arava (leflunomide)
Cardiology using digoxin in WOMEN with heart failure might do more harm than good
Cardiology statins do much more than just lower cholesterol
Cardiology Ezetrol will be the first "cholesterol absorption inhibitor" for hyperlipidemia
Obesity & Weight Loss Topamax (topiramate) for obesity
Ophthalmology Xalacom, the first prostaglandin analog combo product for glaucoma
Gastroenterology irritable bowel syndrome (IBS) patients can benefit from SSRIs
Men's Health drugs compete with Proscar (finasteride) for benign prostatic hyperplasia
Dermatology duct tape for common warts
Natural Medicines questions about coral calcium.
Natural Medicines Many patients don't realize fortified foods can interact with their medications
dissolution changes with a new Dilantin (phenytoin) formulation
Abilify (a-BILA-fī), a new antipsychotic for schizophrenia
questions about smallpox
Commit Lozenge that's expected in Canada next year